BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28246699)

  • 21. Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors.
    Liu S; Zhou F; Liu Z; Xiong A; Jia Y; Zhao S; Zhao C; Li X; Jiang T; Han R; Qiao M; Liu Y; He Y; Li J; Li W; Gao G; Ren S; Su C; Zhou C
    Transl Lung Cancer Res; 2020 Aug; 9(4):1053-1066. PubMed ID: 32953484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
    He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
    Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.
    Zell JA; Ignatius Ou SH; Ziogas A; Anton-Culver H
    J Thorac Oncol; 2007 Dec; 2(12):1078-85. PubMed ID: 18090578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassification.
    Merkel S; Weber K; Croner RS; Golcher H; Göhl J; Agaimy A; Semrau S; Siebler J; Wein A; Hohenberger W; Wittekind C
    Eur J Surg Oncol; 2016 Sep; 42(9):1337-42. PubMed ID: 27160353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.
    Nicholson AG; Chansky K; Crowley J; Beyruti R; Kubota K; Turrisi A; Eberhardt WE; van Meerbeeck J; Rami-Porta R; ;
    J Thorac Oncol; 2016 Mar; 11(3):300-11. PubMed ID: 26723244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy.
    Kadono Y; Nohara T; Ueno S; Izumi K; Kitagawa Y; Konaka H; Mizokami A; Onozawa M; Hinotsu S; Akaza H; Namiki M
    World J Urol; 2016 Feb; 34(2):261-7. PubMed ID: 26047654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
    Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
    J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The revised TNM staging system for lung cancer.
    Rami-Porta R; Crowley JJ; Goldstraw P
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of the innovations in the primary tumour and metastasis of the 8
    Rami-Porta R; Eberhardt WEE
    J Thorac Dis; 2018 Aug; 10(Suppl 22):S2682-S2685. PubMed ID: 30345105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system.
    Jhun BW; Lee KJ; Jeon K; Suh GY; Chung MP; Kim H; Kwon OJ; Sun JM; Ahn JS; Ahn MJ; Park K; Choi JY; Lee KS; Han J; Um SW
    Lung Cancer; 2013 Jul; 81(1):65-70. PubMed ID: 23523420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging of lung cancer in a tertiary care setting in Sri Lanka, using TNM 7th edition. A comparison against TNM6.
    Dassanayake DL; Muthunayake TM; Senevirathna KH; Siribaddana A
    BMC Res Notes; 2012 Mar; 5():143. PubMed ID: 22414168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
    Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
    J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.
    Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Ishihara M; Kasajima M; Nakahara Y; Otani S; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Naoki K
    Cancer Manag Res; 2018; 10():6039-6047. PubMed ID: 30538553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligometastatic non-small cell lung cancer (NSCLC): adrenal metastases. Experience in a single institution.
    Barone M; Di Nuzzo D; Cipollone G; Camplese P; Mucilli F
    Updates Surg; 2015 Dec; 67(4):383-7. PubMed ID: 26589602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 8
    Lim W; Ridge CA; Nicholson AG; Mirsadraee S
    Quant Imaging Med Surg; 2018 Aug; 8(7):709-718. PubMed ID: 30211037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.
    Heesterman BL; van der Poel HG; Schoots IG; Mehra N; Aben KKH
    BJU Int; 2022 Aug; 130(2):217-225. PubMed ID: 34741789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy.
    Hu F; Peng J; Mao X; Niu Y; Ma M; Zhao Y; Gu A; Jiang L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3171-3184. PubMed ID: 35882652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer Patients.
    Yamaguchi M; Edagawa M; Suzuki Y; Toyozawa R; Hirai F; Nosaki K; Seto T; Takenoyama M; Ichinose Y
    Ann Thorac Surg; 2017 May; 103(5):1594-1599. PubMed ID: 27863731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.
    Detterbeck FC; Marom EM; Arenberg DA; Franklin WA; Nicholson AG; Travis WD; Girard N; Mazzone PJ; Donington JS; Tanoue LT; Rusch VW; Asamura H; Rami-Porta R; ; ;
    J Thorac Oncol; 2016 May; 11(5):666-680. PubMed ID: 26940527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.